
Read More
Nifty and Sensex Extend Losses; Midcaps, Small-caps Hit 1-Month Lows...
At the closing bell, the Nifty 50 declined by 156.10 points or 0.63 per cent to end at 24,680.90, wh...

At the closing bell, the Nifty 50 declined by 156.10 points or 0.63 per cent to end at 24,680.90, wh...

Pharma Company Expands Injectable Portfolio with New Launch Targeting U.S. Hospital Market...

The Company Receives Establishment Inspection Report (EIR) from the U.S. FDA for Its Manufacturing F...

FDA-Approved & Ready! This Pharma Giant Targets a USD 113 Million Market!...

A leading player in personal protection and healthcare products expands its international footprint...

FDA Nod for Key Diabetes Treatment Boosts Market Confidence and Stock Performance...

A key injectable biosimilar gets the green light from Japan, driving a 4.5 per cent surge in stock p...

With the USFDA's green light, the Indian pharmaceutical company is poised to expand its product port...

Indian Pharma company breaks into European Market with High-Potential Product, Promising New Revenue...

Nifty 50 Slips, But Broader Markets Lead the Charge; Consumer Durables and Pharma Sectors Outperform...